HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Yasuyo Ohi Selected Research

Formaldehyde (Formol)

8/2006Expression of wild-type estrogen receptor beta protein in human breast cancer: specific correlation with HER2/neu overexpression.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Yasuyo Ohi Research Topics

Disease

29Breast Neoplasms (Breast Cancer)
03/2024 - 03/2002
19Neoplasms (Cancer)
03/2024 - 08/2002
9Ductal Carcinoma
02/2020 - 03/2002
7Triple Negative Breast Neoplasms
09/2023 - 04/2011
6Carcinoma (Carcinomatosis)
12/2018 - 03/2002
5Neoplasm Metastasis (Metastasis)
11/2023 - 04/2013
4Lymphatic Metastasis
09/2018 - 01/2006
3Lobular Carcinoma
01/2024 - 11/2014
3Noninfiltrating Intraductal Carcinoma (DCIS)
03/2021 - 08/2002
1Pathologic Complete Response
01/2019
1Glioma (Gliomas)
03/2017
1Astrocytoma (Pilocytic Astrocytoma)
03/2017
1Mucocele
04/2011
1Cysts
04/2011
1Bone Fractures (Bone Fracture)
07/2010
1Carcinogenesis
05/2007

Drug/Important Bio-Agent (IBA)

6Proteins (Proteins, Gene)FDA Link
11/2023 - 03/2002
6ParaffinIBA
10/2011 - 03/2002
5human ERBB2 proteinIBA
10/2023 - 01/2013
5Messenger RNA (mRNA)IBA
01/2022 - 03/2002
5Estrogen ReceptorsIBA
12/2017 - 03/2002
4Keratin-19 (Keratin 19)IBA
11/2023 - 04/2013
4Nucleic AcidsIBA
01/2022 - 04/2013
3EnzymesIBA
11/2023 - 11/2014
3Hormones (Hormone)IBA
10/2023 - 01/2006
3AndrogensIBA
02/2020 - 11/2014
3SERPIN-B5 (maspin)IBA
12/2018 - 08/2002
3Trastuzumab (Herceptin)FDA Link
10/2018 - 01/2013
3AntibodiesIBA
04/2011 - 08/2002
2DNA (Deoxyribonucleic Acid)IBA
03/2024 - 11/2023
2CytokinesIBA
09/2023 - 12/2017
2GlucocorticoidsIBA
08/2023 - 02/2020
2Progesterone Receptors (Progesterone Receptor)IBA
01/2022 - 05/2007
2Eosine Yellowish-(YS) (Eosin)IBA
03/2021 - 01/2016
2Growth Factor ReceptorsIBA
02/2020 - 01/2016
2Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link
02/2020 - 02/2018
2Peptides (Polypeptides)IBA
07/2018 - 08/2014
2Biomarkers (Surrogate Marker)IBA
01/2017 - 06/2015
2Indicators and Reagents (Reagents)IBA
10/2011 - 03/2002
2Aldehyde Dehydrogenase 1 FamilyIBA
10/2011 - 03/2011
2Estrogen Receptor alphaIBA
05/2007 - 08/2006
2StreptavidinIBA
08/2002 - 03/2002
2Biotin (Vitamin H)FDA Link
08/2002 - 03/2002
1InterleukinsIBA
09/2023
1Interleukin-17 (Interleukin 17)IBA
09/2023
1VimentinIBA
01/2019
1multidrug resistance-associated protein 1IBA
01/2019
1Aromatase (CYP19)IBA
07/2018
1Testosterone CongenersIBA
12/2017
1Estradiol Congeners (Synthetic Estrogens)IBA
12/2017
1GadoliniumIBA
03/2017
1NimustineIBA
03/2017
1Isocitrate Dehydrogenase (Isocitrate Dehydrogenase (NAD+))IBA
03/2017
1Temozolomide (Temodar)FDA LinkGeneric
03/2017
1Lapatinib (GW572016)FDA Link
01/2017
1Capecitabine (Xeloda)FDA Link
01/2017
1Phenobarbital (Luminal)FDA Link
02/2016
1Estrogens (Estrogen)FDA Link
02/2016
1ErbB Receptors (EGF Receptor)IBA
01/2016
1Hematoxylin (Haematoxylon)IBA
01/2016
1Androgen Receptors (Androgen Receptor)IBA
11/2014
1Calmodulin (Calcium-Dependent Activator Protein)IBA
08/2014
1MucinsIBA
04/2011
1Anastrozole (Arimidex)FDA LinkGeneric
07/2010
1Aromatase InhibitorsIBA
07/2010
1Diphosphonates (Bisphosphonates)IBA
07/2010
1Protein Isoforms (Isoforms)IBA
08/2006
1Formaldehyde (Formol)FDA Link
08/2006
1Monoclonal AntibodiesIBA
08/2006
1Estrogen Receptor betaIBA
08/2006

Therapy/Procedure

10Therapeutics
01/2024 - 07/2010
4Drug Therapy (Chemotherapy)
10/2023 - 03/2017
3Mastectomy (Mammectomy)
07/2019 - 03/2002
2Segmental Mastectomy (Lumpectomy)
08/2002 - 03/2002
1Neoadjuvant Therapy
01/2019
1Adjuvant Chemotherapy
10/2018
1Radiotherapy
03/2017